SAGE mRNA expression in advanced-stage lung cancers.

Area of Science:

• Oncology
• Molecular Biology
• Cancer Diagnostics

Background:

• SAGE and HAGE are recently identified genes with potential roles in tumor-specific antigen expression.
• Their expression could serve as diagnostic markers for malignant diseases.
• This study investigates the correlation of SAGE and HAGE expression with clinicopathological features in lung cancer.

Purpose of the Study:

• To evaluate the correlation between SAGE and HAGE gene expression and clinicopathological features in lung cancer patients.
• To determine the potential diagnostic utility of SAGE and HAGE mRNA detection in lung cancer.

Main Methods:

• Messenger RNA (mRNA) expression of SAGE and HAGE was assessed using reverse transcription-polymerase chain reaction (RT-PCR).
• The study included 102 lung carcinomas and adjacent normal lung tissues.
• LightCycler technology was employed for gene expression analysis.

Main Results:

• SAGE/GAPDH mRNA expression did not differ significantly between lung cancer tissue and normal lung tissue.
• SAGE/GAPDH expression was significantly higher in advanced stages (III-IV) and higher T-stages (T4) of lung cancer.
• No relationship was found between SAGE gene expression and patient age, gender, or N-status.
• HAGE gene expression showed no correlation with any clinicopathological factors.

Conclusions:

• SAGE mRNA expression is detectable in lung cancer samples.
• SAGE mRNA expression levels correlate with advanced tumor stage and size in lung cancer.
• HAGE gene expression lacks correlation with clinicopathological factors, suggesting limited utility for HAGE mRNA detection in lung cancer diagnosis.